Health Catalyst
HCAT
130 hedge funds and large institutions have $70.8M invested in Health Catalyst in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 31 closing their positions.
51% more call options, than puts
Call options by funds: $3.15M | Put options by funds: $2.08M
8% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 36
3% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 31
2.31% less ownership
Funds ownership: 78.11% → 75.79% (-2.3%)
4% less funds holding
Funds holding: 136 → 130 (-6)
46% less capital invested
Capital invested by funds: $132M → $70.8M (-$61.2M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
CDC Financial
Chicago,
Illinois
|
+$4.34M |
| 2 |
PVM
Palogic Value Management
Dallas,
Texas
|
+$3.06M |
| 3 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$1.45M |
| 4 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
|
+$974K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$862K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.59M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.9M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.54M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.39M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$856K |
HCAT Hedge Fund Activity: Q1 2026 in Review
130 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q1 2026, worth a combined $70.8M — down 46% from $132M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of HCAT and 30 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 39 added.
The largest buyer was CDC Financial, adding an estimated $4.34M. The largest seller was Millennium Management, exiting entirely with an estimated $2.59M sold.
- 130 institutional investors held Health Catalyst (HCAT) as of Q1 2026, down from 136 in Q4 2025.
- Funds reported $70.8M of Health Catalyst stock for Q1 2026, down 46% quarter-over-quarter.
- 30 funds opened new Health Catalyst positions in Q1 2026 and 31 closed out, a net change of -1 holder.
- The largest Health Catalyst buyer in Q1 2026 was CDC Financial, an estimated $4.34M added.
- The largest Health Catalyst seller in Q1 2026 was Millennium Management, an estimated $2.59M sold.
Based on aggregated 13F filings for Q1 2026.